semaglutide weight loss graph Comparative weight-loss response profiles and longitudinal trajectories GLP-1 agonists for weight loss:

Health and Safety Keywords GLP-1 long-term safety GLP-1 interactions with other medications GLP-1 and heart health GLP-1 clinical studies GLP-1 FDA approval status Readers are increasingly interested in safety and clinical outcomes

doi: 10.1158/2326-6066.CIR-20-0384 39 WangHFrancoFTsuiYCXieXTrefnyMPZappasodiRet al

Start with the lowest dose to minimise GI side effects and titrate based on patient tolerance

However, clinically significant improvements in overall glycemic control should not be expected during the initial month, as this dose is primarily intended for gastrointestinal adaptation rather than maximal therapeutic effect

Amount Per Serving (1 capsule)

Other tissues, like the vascular endothelium and the liver, are also vulnerable to damage caused by inflammation [73]